Go Pro

Generate Biomedicines (GENB) News Today

Generate Biomedicines logo
$16.34 +0.06 (+0.37%)
As of 04:00 PM Eastern

Generate Biomedicines Latest News

Wall Street Zen Upgrades Generate Biomedicines (NASDAQ:GENB) to Hold
Generate Biomedicines Stock Price History
Generate Biomedicines surges again, rises 12% to new high
Generate Biomedicines, Inc. (GENB)
Generate Biomedicines Inc GENB
Generate Biomedicines Inc (GENB)
A Deep Dive Into NVIDIA’s Latest Portfolio Moves (GENB)
NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.
8 Best Low Priced Biotech Stocks to Invest In
Generate Biomedicines Inc.
Generate Biomedicines IPO Turns Heads

Generate Biomedicines Media Mentions By Week

Generate Biomedicines Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GENB
News Sentiment

0.70

0.78

Average
Healthcare
News Sentiment

Generate Biomedicines News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GENB Articles
This Week

4

2

GENB Articles
Average Week

Generate Biomedicines Trends on MarketBeat

This week vs. last week
New Followers
5
+150%
Searches
4
+33%
Page Views
2,550
+3%
Get Generate Biomedicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENB and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Generate Biomedicines dated 9/3/2026.
From Our Partners